FDA Clearance Tracker · K203772
Omnipod 5 SmartBolus Calculator
Last checked: Nov 19, 2026Latest source record: Jan 27, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Jan 27, 2022
Substantially Equivalent
Time to decision
400 days
Received Dec 23, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K203772
- Device name
- Omnipod 5 SmartBolus Calculator
- Applicant
- Insulet Corporation
- Applicant location
- Acton, MA
- Received
- Dec 23, 2020
- Decided
- Jan 27, 2022
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 862.1358
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code QRX (Continuous Glucose Monitor Informed Insulin Dose Calculator).
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
- FDA database record for K203772
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Insulet Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Omnipod 6 algorithm510(k)
K261461 · Decided Jun 29, 2026 · 56 days after receipt
Device type: Interoperable Automated Glycemic Controller (QJI) · Laboratory Medicine & Pathology
- Omnipod 5 algorithm510(k)
K251779 · Decided Dec 3, 2025 · 176 days after receipt
Device type: Interoperable Automated Glycemic Controller (QJI) · Laboratory Medicine & Pathology
- SmartAdjust Technology510(k)
K241777 · Decided Aug 26, 2024 · 67 days after receipt
Device type: Interoperable Automated Glycemic Controller (QJI) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.